Discover how the coverage-gap score reveals companies with few equity analysts vs market cap, highlighting risks, opportunities, and undervalued stocks in 2025.
J&J reports durability data for bladder cancer 'pretzel' drug TAR-200, showing a 72.7% complete response rate and sustained benefits after FDA filing.
The rise of green energy: how renewable energy is transforming the tech industry in 2025 through AI, data centers, and innovative energy solutions.
Green Pharma is revolutionizing the pharmaceutical industry by using renewable energy to cut emissions, reduce waste, and promote sustainable drug manufacturing.